Core--Research development

核心--研究开发

• 批准号: 6442901
• 负责人: JOHN NMN PAPACONSTANTINOU
• 金额: $ 15.92万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-04-15 至 2002-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6442901
• 关键词: aging; biomedical facility; geriatrics; training

The aim of the Research Development Core (RDC) is to develop and support a high quality research and training program for the enhancement and improvement of independence of older Americans. Five pilot projects analyze the physiological development of age-associated muscle atrophy (sarcopenia). They serve as the basis for a multi-disciplinary research and training program designed to develop junior faculty and post-doctoral fellows who are deeply committed to academic careers in geriatrics and gerontology. The specific aims of the RDC are to: 1. Provide a structured research and didactic training program in gerontology and geriatrics for career development of promising junior faculty and post-doctoral fellows. 2. Promote the growth of research on aging at UTMB by encouraging established investigators in other fields to turn their efforts to aging research by (a) mentoring pilot research projects relevant to OAIC; (b) incorporate aging issues in their research programs and (c) assisting in the development of interdisciplinary aging research projects to the OAIC. By teaming mentors and trainee investigators on pilot projects, and through interactions with senior investigators, the RDC offers a comprehensive training program that spans from detailed mechanistic studies based on animal models to clinical interventions.

研究开发核心（RDC）的目标是开发和支持高质量的研究和培训计划，以增强和改善美国老年人的独立性。五个试点项目分析了与年龄相关的肌肉萎缩（肌少症）的生理发育。它们是多学科研究和培训计划的基础，旨在培养致力于老年病学和老年学学术事业的初级教师和博士后研究员。 RDC 的具体目标是： 1. 为有前途的初级教师和博士后研究员的职业发展提供老年学和老年医学方面的结构化研究和教学培训计划。 2. 通过鼓励其他领域的知名研究人员将精力转向老龄化研究，促进 UTMB 老龄化研究的发展：(a) 指导与 OAIC 相关的试点研究项目； (b) 将老龄化问题纳入其研究计划，以及 (c) 协助 OAIC 制定跨学科老龄化研究项目。通过在试点项目上与导师和实习研究人员合作，并通过与高级研究人员的互动，RDC 提供了全面的培训计划，涵盖从基于动物模型的详细机制研究到临床干预。